Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03662035
What this trial is testing

Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Changzhou No.2 People's Hospital 30
Not applicableUnknownNCT03567135
What this trial is testing

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Who this might be right for
Glioblastoma
Fuzhou General Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06749691
What this trial is testing

Liposomal Irinotecan and Apatinib in ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT04476459
What this trial is testing

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma Grade IIIb+3 more
Huiqiang Huang 33
Large-scale testing (Phase 3)Looking for participantsNCT05789043
What this trial is testing

Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma

Who this might be right for
Acral Melanoma
Peking University Cancer Hospital & Institute 140
Testing effectiveness (Phase 2)UnknownNCT03424291
What this trial is testing

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06280508
What this trial is testing

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Not applicableUnknownNCT03671265
What this trial is testing

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06576973
What this trial is testing

Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Treatment
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Testing effectiveness (Phase 2)UnknownNCT03411967
What this trial is testing

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

Who this might be right for
Lung Cancer
Zigong No.1 Peoples Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT04501718
What this trial is testing

Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children

Who this might be right for
Recurrent Medulloblastoma
Beijing Sanbo Brain Hospital 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06745193
What this trial is testing

A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Carcinoma
Peking University 63
Testing effectiveness (Phase 2)Study completedNCT04338438
What this trial is testing

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

Who this might be right for
Gastric Cancer
Beijing Friendship Hospital 37
Testing effectiveness (Phase 2)UnknownNCT03954756
What this trial is testing

Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Henan Cancer Hospital 35
Testing effectiveness (Phase 2)UnknownNCT02768415
What this trial is testing

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Looking for participantsNCT06429696
What this trial is testing

PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Nanfang Hospital, Southern Medical University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451290
What this trial is testing

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Carcinoma
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)UnknownNCT03416231
What this trial is testing

Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)

Who this might be right for
NSCLC
Affiliated Hospital of North Sichuan Medical College 20
Testing effectiveness (Phase 2)Looking for participantsNCT07479732
What this trial is testing

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma Metastatic
Peking University People's Hospital 56
Testing effectiveness (Phase 2)UnknownNCT04612894
What this trial is testing

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 31
Next Page